Kate McLean MD, MPH, FACOG

Kate McLean, MD, describes how newly defined bacterial vaginosis subtypes could validate patient symptoms and inform treatment.

Kate McLean, MD, MPH, FACOG, describes how statistical clustering of more than 15,000 BV-diagnosed patients surfaced distinct microbial subtypes without predefined assumptions.

Kate McLean, MD, MPH, FACOG, describes how metagenomic sequencing and new transmission data are reshaping the understanding of bacterial vaginosis beyond a traditional, oversimplified definition.